La Habana Vieja in Springfield shuts down due to staff limits
Cuban-style restaurant La Habana Vieja on Commercial street in Springfield says it's closing its doors immediately, citing a lack of ability to work.
The restaurant opened in 2021 and is owned by Ted Tabor and Freddie Flores, according to La Habana Vieja's website.
It boasted a large menu of food and cocktails, calling the establishment on social media, 'A taste of authentic Cuban cuisine in Springfield, Missouri.'
On Wednesday, May 14th, the restaurant posted a photo on its Facebook page detailing the reason for the closure.
The post states the restaurant was staffed with Cuban people, but in recent days, 'our government has elected to rescind their ability to work, thus forcing their departure from the La Habana Vieja and the USA.'
It also state kitchen and bar were primary made up of staff from Cuba, who were 'working hard to secure their part of the 'American Dream.''
The document posted is dated May 13, 2025, and signed by Ted Tabor, Freddie Flores, and Hope Choate.
The restaurant is now expected to close its doors following dinner on Wednesday, May 14th.
The post has garnered hundreds of likes, shares and comments, with many commentors saying the closure means a big loss for the community.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 minutes ago
- Yahoo
Here's Why GSK (GSK) is a Strong Value Stock
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Achieving those goals is made easier with the Zacks Style Scores, a unique set of guidelines that rates stocks based on popular investing methodologies, namely value, growth, and momentum. The Style Scores can help you narrow down which stocks are better for your portfolio and which ones can beat the market over the long-term. Finding good stocks at good prices, and discovering which companies are trading under their true value, are what value investors like to focus on. So, the Value Style Score takes into account ratios like P/E, PEG, Price/Sales, and Price/Cash Flow to highlight the most attractive and discounted stocks. GSK has three segments: Specialty Medicines (HIV, Oncology, Immunology/Respiratory and Other), Vaccines (Meningitis, Influenza, Shingles, RSV and Established Vaccines) and General Medicines (Respiratory and Other), which are clubbed as commercial operations. GSK boasts a Value Style Score of A and VGM Score of B, and holds a Zacks Rank #2 (Buy) rating. Shares of GSK are trading at a forward earnings multiple of 9.5X, as well as a PEG Ratio of 1.6, a Price/Cash Flow ratio of 7.4X, and a Price/Sales ratio of 2.1X. Many value investors pay close attention to a company's earnings as well. For GSK, five analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.12 to $4.32 per share for 2025. Per share GSK boasts an average earnings surprise of 8.6%. Investors should take the time to consider GSK for their portfolios due to its solid Zacks Ranks, notable earnings and valuation metrics, and impressive Value and VGM Style Scores. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report GSK PLC Sponsored ADR (GSK) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
17 minutes ago
- Yahoo
ACM Research, Inc. (ACMR) is Attracting Investor Attention: Here is What You Should Know
ACM Research, Inc. (ACMR) has recently been on list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future. Over the past month, shares of this company have returned +5.3%, compared to the Zacks S&P 500 composite's +5.3% change. During this period, the Zacks Semiconductor Equipment - Material Services industry, which ACM Research falls in, has gained 15.3%. The key question now is: What could be the stock's future direction? Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision. Here at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock. We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. For the current quarter, ACM Research is expected to post earnings of $0.42 per share, indicating a change of -23.6% from the year-ago quarter. The Zacks Consensus Estimate has changed -13.3% over the last 30 days. The consensus earnings estimate of $2 for the current fiscal year indicates a year-over-year change of -11.5%. This estimate has changed -2.2% over the last 30 days. For the next fiscal year, the consensus earnings estimate of $2.20 indicates a change of +10% from what ACM Research is expected to report a year ago. Over the past month, the estimate has changed -12%. Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, ACM Research is rated Zacks Rank #4 (Sell). The chart below shows the evolution of the company's forward 12-month consensus EPS estimate: Even though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial. In the case of ACM Research, the consensus sales estimate of $221.04 million for the current quarter points to a year-over-year change of +9.2%. The $912.29 million and $1.06 billion estimates for the current and next fiscal years indicate changes of +16.6% and +16.6%, respectively. ACM Research reported revenues of $172.35 million in the last reported quarter, representing a year-over-year change of +13.3%. EPS of $0.46 for the same period compares with $0.52 a year ago. Compared to the Zacks Consensus Estimate of $162.5 million, the reported revenues represent a surprise of +6.06%. The EPS surprise was +24.32%. The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates each time over this period. No investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance. While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S) and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price. As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued. ACM Research is graded C on this front, indicating that it is trading at par with its peers. Click here to see the values of some of the valuation metrics that have driven this grade. The facts discussed here and much other information on might help determine whether or not it's worthwhile paying attention to the market buzz about ACM Research. However, its Zacks Rank #4 does suggest that it may underperform the broader market in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report ACM Research, Inc. (ACMR) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
Yahoo
18 minutes ago
- Yahoo
Why Match Group (MTCH) is a Top Growth Stock for the Long-Term
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. While you may have an investing style you rely on, finding great stocks is made easier with the Zacks Style Scores. These are complementary indicators that rate stocks based on value, growth, and/or momentum characteristics. Different than value or momentum investors, growth-oriented investors are concerned with a stock's future prospects, and the overall financial health and strength of a company. Thus, they'll want to focus on the Growth Style Score, which analyzes characteristics like projected and historical earnings, sales, and cash flow to find stocks that will see sustainable growth over time. Match Group, Inc. is the world's foremost provider of dating products and operates a portfolio of more than 45 brands. Its biggest and best known brands are Tinder, PlentyOfFish, Meetic and OkCupid. The Dallas, TX-based company offers dating products in 42 languages in more than 190 countries. MTCH boasts a Growth Style Score of A and VGM Score of A, and holds a Zacks Rank #3 (Hold) rating. Its bottom-line is projected to rise 13% year-over-year for 2025, while Wall Street anticipates its top line to improve by 0.9%. One analyst revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.08 to $3.38 per share for 2025. MTCH boasts an average earnings surprise of 2.1%. On a historic basis, Match Group has generated cash flow growth of 10.1%, and is expected to report cash flow expansion of 1.4% this year. Investors should take the time to consider MTCH for their portfolios due to its solid Zacks Rank rating, notable growth metrics, and impressive Growth and VGM Style Scores. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Match Group Inc. (MTCH) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
